Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
- Status
- RECRUITING
- Phase
- PHASE1
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC
- Status
- RECRUITING
- Phase
- N/A
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain
- Status
- COMPLETED
- Phase
- N/A
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- Status
- RECRUITING
- Phase
- PHASE1
Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
- Status
- RECRUITING
- Phase
- PHASE3
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
- Status
- RECRUITING
- Phase
- PHASE3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Anifrolumab Malignancy and Serious Infections Study
- Status
- RECRUITING
- Phase
- N/A
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
- Status
- NOT_YET_RECRUITING
- Phase
- N/A